Thursday, June 13, 2013

Media Advisory: CDC's Advisory Committee on Immunization Practices Meeting

For Immediate Release: Tuesday, June 12, 2013
Contact: CDC Media Relations, Office of Communication
(404) 639-3286


Please Note the Need to RSVP

What

Meeting of the Advisory Committee on Immunization Practices (ACIP)

When

Wednesday, June 19th; 8:00 am - 5:30 pm ET
Thursday, June 20th; 8:00 am - 3:15 pm ET

Where

Centers for Disease Control and Prevention
1600 Clifton Road NE
Atlanta, GA 30329

Tom Harkin Global Communications Center (Building 19), Kent “Oz” Nelson Auditorium
For directions to CDC, please visit http://www.cdc.gov/about/resources/visitGuide.htm#direction

Webstream

If you cannot attend the meeting in person, it will be web streamed. More information can be found at http://www.cdc.gov/vaccines/acip/meetings/webcast-instructions.html

Background

An agenda for the meeting can be found at http://www.cdc.gov/vaccines/recs/acip/. The Advisory Committee on Immunization Practices (ACIP) consists of 15 experts in fields associated with immunization who have been selected by the Secretary of the U.S. Department of Health and Human Services to provide advice and guidance to the Secretary and the Assistant Secretary for Health, and the Director of the Centers for Disease Control and Prevention (CDC) on control of vaccine-preventable diseases.
The Committee develops written recommendations for   use of vaccines that are licensed in the United States; considerations include age for vaccine administration, number of doses and dosing interval, safety issues, and precautions and contraindications.
Special Note – reporters who wish to attend the meeting in person must RSVP to Jamila Jones, in CDC's Division of Public Affairs at jhoward2@cdc.gov by COB on Friday, June 14th. Space is limited, and only those reporters who RSVP will be guaranteed working space during the meeting.
To RSVP attendance at ACIP meeting, please contact 404-639-3286.

http://www.cdc.gov/media/releases/2013/a0612-immunization-practices.html

No comments: